PQ Bypass logo — Leading the charge in minimally-invasive treatments for long...

PQ Bypass

Leading the charge in minimally-invasive treatments for long-segment peripheral artery disease with deep industry expertise and innovation-driven solutions

Founded 2009 Private Equity Total: $70.04M Health Care, Medical Devices

General Information

Company Name PQ Bypass
Founded Year 2009
Industries Health Care, Medical Devices
Funding Stage Private Equity
Social

Get notified when PQ Bypass moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PQ Bypass

**PQ Bypass** is a Silicon Valley-based medical device company aiming to enhance the treatment of long-segment peripheral artery disease through minimally-invasive endovascular solutions. Founded in **2009**, it was previously a Company-In-Residence at the Fogarty Institute for Innovation. The leadership team comprises professionals with extensive experience in the medical device sector, having held senior roles at renowned companies such as **Medtronic**, **Abbott**, **Johnson & Johnson**, **Covidien**, and **Stryker**, while also contributing to the development of medical devices for venture-backed startups like **Evalve**, **AccessClosure**, **Altura**, and **DVI**. The company recently secured a significant **$60.00M** Private Equity Round investment on **08 January 2019**. This funding round saw participation from notable investors including **Medical Technology Venture Partners**, **Seroba Life Sciences**, and **Deerfield Capital Management**. PQ Bypass' dedication to innovation and its leadership's deep industry expertise position the company as a pivotal player in the minimally-invasive treatments realm within the **Health Care** and **Medical Devices** industries. With its strong investor backing and experienced leadership, PQ Bypass is primed to make a significant impact in the medical device landscape.

Taxonomy: medical device industry, minimally-invasive treatments, endovascular solutions, peripheral artery disease, Silicon Valley, Fogarty Institute for Innovation, venture-backed startups, Medtronic, Abbott, Johnson & Johnson, Covidien, Stryker, evalve, AccessClosure, DVI

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round •••••• 3
Investor Investor Investor
08 Jan 2019
Venture Round •••••• - 22 Apr 2016

PQ Bypass Alternatives & Competitors

PQ Bypass vs

International consulting and market research firm dedicated to the medical device, dental, and pharm...

58 employees
Marketing
PQ Bypass vs

Elevating the future of hearing technology with innovation and expertise.

Debt Financing
Health Care, Manufacturing
PQ Bypass vs

Your partner in advanced ophthalmic diagnostics and treatment in Belgium and Luxembourg

17 employees
Health Care, Medical Devices

FAQ About PQ Bypass

Leading the charge in minimally-invasive treatments for long-segment peripheral artery disease with deep industry expertise and innovation-driven solutions
PQ Bypass was founded in 2009.
PQ Bypass operates in the following industries: Health Care, Medical Devices.
PQ Bypass has completed 2 funding rounds, raising a total of $70.04M. The latest funding stage is Private Equity.
Top alternatives and competitors to PQ Bypass include iData Research, InSound Medical, De Ceunynck Ophthalmology, Abiomed, PRODUCTOS MÉDICOS Y HOSPITALARIOS SA. DE CV. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PQ Bypass and iData Research are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PQ Bypass and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy